Related references
Note: Only part of the references are listed.Novel De Novo SHANK3 Mutation in Autistic Patients
Julie Gauthier et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Genetics of autism spectrum disorders
Ravinesh A. Kumar et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3
A. Delahaye et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2009)
Primary ovarian insufficiency: X chromosome defects and autoimmunity
Luca Persani et al.
JOURNAL OF AUTOIMMUNITY (2009)
OPINION The consequences of asynapsis for mammalian meiosis
Paul S. Burgoyne et al.
NATURE REVIEWS GENETICS (2009)
The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders
Catalina Betancur et al.
TRENDS IN NEUROSCIENCES (2009)
Primary ovarian insufficiency: a more accurate term for premature ovarian failure
Corrine K. Welt
CLINICAL ENDOCRINOLOGY (2008)
Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development
Heather L. Wilson et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Contribution of SHANK3 mutations to autism spectrum disorder
Rainald Moessner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
X chromosome and ovarian failure
Daniela Toniolo et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2007)
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis
Flavio Rizzolio et al.
HUMAN GENETICS (2007)
Premature ovarian failure: a review
T. A. Nippita et al.
CLIMACTERIC (2007)
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Christelle M. Durand et al.
NATURE GENETICS (2007)
Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome
M. C. Bonaglia et al.
JOURNAL OF MEDICAL GENETICS (2006)
Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients
M. F. Portnoi et al.
HUMAN REPRODUCTION (2006)
Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature
Flavio Rizzolio et al.
HUMAN REPRODUCTION (2006)
Premature ovarian failure
Paolo Beck-Peccoz et al.
ORPHANET JOURNAL OF RARE DISEASES (2006)
An update: spontaneous premature ovarian failure is not an early menopause
LM Nelson et al.
FERTILITY AND STERILITY (2005)
Distinct DNA-damage-dependent and -independent responses drive the loss of oocytes in recombination-defective mouse mutants
M Di Giacomo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genes and translocations involved in POF
D Schlessinger et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
FISH-mapping of a 100-kb terminal 22q13 deletion
BM Anderlid et al.
HUMAN GENETICS (2002)
Most X ; autosome translocations associated with premature ovarian failure do not interrupt X-linked genes
RL Prueitt et al.
CYTOGENETIC AND GENOME RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome
MC Bonaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes
S Mumm et al.
GENOMICS (2001)